Jin Hee Ahn - Search Results

Year	Number of Results
1996	1
1998	1
2002	6
2003	3
2004	7
2005	9
2006	6
2007	11
2008	7
2009	9
2010	13
2011	24
2012	18
2013	21
2014	21
2015	20
2016	19
2017	13
2018	15
2019	28
2020	32
2021	37
2022	25
2023	16
2024	4

1

Favorable clinical efficacy of cytotoxic chemotherapy in patients with progressive desmoid tumors: a retrospective real-world study.

Oh CR, Jeong H, Kim W, Lee JS, Song SY, Song JS, Cho KJ, Chung HW, Lee MH, Hong JY, Lee J, Kim JE, Ahn JH. Oh CR, et al. Among authors: ahn jh. Int J Clin Oncol. 2024 Mar 25. doi: 10.1007/s10147-024-02506-2. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38526622

2

Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II Study.

Ahn JH, Lee J, Park C, Beom SH, Kim SH, Lee YH, Yun KH, Kim JE, Baek W, Han YD, Kim SK, Ryu HJ, Jung I, Lee J, Yoon HI, Kim HS. Ahn JH, et al. Clin Cancer Res. 2024 Apr 15;30(8):1457-1465. doi: 10.1158/1078-0432.CCR-23-2823. Clin Cancer Res. 2024. PMID: 38363333 Clinical Trial.

3

Discovery of a peripheral 5HT_2A antagonist as a clinical candidate for metabolic dysfunction-associated steatohepatitis.

Pagire HS, Pagire SH, Jeong BK, Choi WI, Oh CJ, Lim CW, Kim M, Yoon J, Kim SS, Bae MA, Jeon JH, Song S, Lee HJ, Lee EY, Goughnour PC, Kim D, Lee IK, Loomba R, Kim H, Ahn JH. Pagire HS, et al. Among authors: ahn jh. Nat Commun. 2024 Jan 20;15(1):645. doi: 10.1038/s41467-024-44874-3. Nat Commun. 2024. PMID: 38245505 Free PMC article.

4

Dynamic Arterial Elastance as a Predictor of Supine-to-Prone Hypotension (SuProne Study): An Observational Study.

Ahn JH, Park J, Shim JG, Lee SH, Ryu KH, Jeong T, Cho EA. Ahn JH, et al. Medicina (Kaunas). 2023 Nov 21;59(12):2049. doi: 10.3390/medicina59122049. Medicina (Kaunas). 2023. PMID: 38138152 Free PMC article.

5

Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Takahashi M, Cortés J, Dent R, Pusztai L, McArthur H, Kümmel S, Denkert C, Park YH, Im SA, Ahn JH, Mukai H, Huang CS, Chen SC, Kim MH, Jia L, Li XT, Tryfonidis K, Karantza V, Iwata H, Schmid P. Takahashi M, et al. Among authors: ahn jh. JAMA Netw Open. 2023 Nov 1;6(11):e2342107. doi: 10.1001/jamanetworkopen.2023.42107. JAMA Netw Open. 2023. PMID: 37966841 Free PMC article. Clinical Trial.

6

21-gene expression assay and clinical outcomes of premenopausal patients with hormone receptor-positive breast cancer.

Hyung J, Lee SB, Kim J, Kim HJ, Ko B, Lee JW, Son BH, Lee HJ, Gong G, Jeong H, Jeong JH, Kim JE, Ahn JH, Jung KH, Kim SB. Hyung J, et al. Among authors: ahn jh. Int J Cancer. 2024 Feb 15;154(4):748-756. doi: 10.1002/ijc.34728. Epub 2023 Sep 17. Int J Cancer. 2024. PMID: 37718333

7

Synthesis and biological evaluation of xanthine derivatives with phenacyl group as tryptophan hydroxylase 1 (TPH1) inhibitors for obesity and fatty liver disease.

Yoon J, Choi WI, Parameswaran S, Lee GB, Choi BW, Kim P, Shin DS, Jeong HN, Lee SM, Oh CJ, Jeon JH, Lee IK, Bae MA, Kim H, Ahn JH. Yoon J, et al. Among authors: ahn jh. Bioorg Med Chem Lett. 2023 Oct 1;94:129461. doi: 10.1016/j.bmcl.2023.129461. Epub 2023 Aug 29. Bioorg Med Chem Lett. 2023. PMID: 37652099

8

Association between body composition and chronic low back pain in Korean adults aged over 50 years: The Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2011.

Shim JG, Ryu KH, Cho EA, Ahn JH, Park J, Lee HW, Kang S, Han SY, Lee SH. Shim JG, et al. Among authors: ahn jh. Med Princ Pract. 2023 Aug 7;32(4-5):281-7. doi: 10.1159/000533354. Online ahead of print. Med Princ Pract. 2023. PMID: 37549659 Free PMC article.

9

Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer.

Kang S, Lee SH, Lee HJ, Jeong H, Jeong JH, Kim JE, Ahn JH, Jung KH, Gong G, Kim HH, Lee S, Lee J, Kim SB. Kang S, et al. Among authors: ahn jh. Eur J Cancer. 2023 Sep;191:112956. doi: 10.1016/j.ejca.2023.112956. Epub 2023 Jun 24. Eur J Cancer. 2023. PMID: 37473465 Free article.

10

Inhibition of pyruvate dehydrogenase kinase 4 ameliorates kidney ischemia-reperfusion injury by reducing succinate accumulation during ischemia and preserving mitochondrial function during reperfusion.

Oh CJ, Kim MJ, Lee JM, Kim DH, Kim IY, Park S, Kim Y, Lee KB, Lee SH, Lim CW, Kim M, Lee JY, Pagire HS, Pagire SH, Bae MA, Chanda D, Thoudam T, Khang AR, Harris RA, Ahn JH, Jeon JH, Lee IK. Oh CJ, et al. Among authors: ahn jh. Kidney Int. 2023 Oct;104(4):724-739. doi: 10.1016/j.kint.2023.06.022. Epub 2023 Jul 1. Kidney Int. 2023. PMID: 37399974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

308 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

308 results

Results by year